Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07018232 · ClinicalTrials.gov registry record
Enhancing Timely Access to Medication Changes: The Role of Pharmacists in Overcoming Transitions of Care Challenges
A clinical trial, sponsored by The Guthrie Clinic.
- Completed
- Registry status
- 104
- Enrollment target
NCT07018232: Completed study, sponsored by The Guthrie Clinic.
NCT07018232 is a clinical trial that has completed, run by The Guthrie Clinic. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07018232 has completed, sponsored by The Guthrie Clinic.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
Objective: Among patients discharged from the hospital with changes in maintenance prescription medication, how does experiencing a medication access gap compared to a no medication access gap impact the time to first unplanned healthcare encounter? This is a retrospective, cohort study conducted at two hospital sites in rural Pennsylvania and New York State using encounter data from the electronic health record to analyze any patient discharged with medication changes from June 1, 2023 to May 31, 2024.
Primary Outcome
The study will compare number of days between patients who had a medication gap and patients who had no medication gap
Interventions
- BEHAVIORAL Unplanned healthcare encounter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-11-27 |
| Est. Completion | 2025-05-15 |
What the finished NCT07018232 record still lists
NCT07018232 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Unplanned healthcare encounter is the first listed.
NCT07018232 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07018232 about?
NCT07018232 is a clinical study titled "Enhancing Timely Access to Medication Changes: The Role of Pharmacists in Overcoming Transitions of Care Challenges". Objective: Among patients discharged from the hospital with changes in maintenance prescription medication, how does experiencing a medication access gap compared to a no medication access gap impact the time to first unplanned healthcare encounter? This is a retrospective, cohort study conducted a...
What is the current status of trial NCT07018232?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2024-11-27. Estimated completion is 2025-05-15.
What interventions are being tested in trial NCT07018232?
The interventions under investigation include: Unplanned healthcare encounter (BEHAVIORAL).
Who is sponsoring clinical trial NCT07018232?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI